Alector Stock Quote ALEC - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.48

Bid

6.00

Ask

6.55

Volume

603,811

6.335 Day's Range 6.63

3.66 52 Week Range 9.065

Market Cap

624.572M

Previous Close

6.49

Open

6.57

Last Trade

194961

6.49

(average)

Last Trade Time

Financial Volume

$ 3,908,729

VWAP

6.4734

Average Volume (3m)

646,049

Shares Outstanding

96,384,562

Dividend Yield

PE Ratio

-4.79

Earnings Per Share (EPS)

-1.35

Revenue

97.06M

Net Profit

-130.39M

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.alector.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alector Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ALEC. The last closing price for Alector was $6.49. Over the last year, Alector shares have traded in a share price range of $ 3.66 to $ 9.065.

Alector currently has 96,384,562 shares outstanding. The market capitalization of Alector is $625.54 million. Alector has a price to earnings ratio (PE ratio) of -4.79.

Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.62	10.5802047782	5.86	6.78	5.7021	736800	6.32895212	CS
4	1.95	43.0463576159	4.53	6.78	4.22	598531	5.70198852	CS
12	1.02	18.6813186813	5.46	6.78	4.11	646049	5.11461613	CS
26	0.24	3.84615384615	6.24	7.5773	4.11	657814	5.66468845	CS
52	0.25	4.01284109149	6.23	9.065	3.66	668910	6.00882599	CS
156	-27.13	-80.7200238024	33.61	35.14	3.66	629431	10.86486395	CS
260	-14.82	-69.5774647887	21.3	45	3.66	664269	15.65635868	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M